ImportRefusal LogoImportRefusal

Guangzhou Baiyunshan Pharmaceutical Factory

⚠️ Moderate Risk

FEI: 3006532121 • Guangzhou, Guangdong • CHINA

FEI

FEI Number

3006532121

📍

Location

Guangzhou, Guangdong

🇨🇳

Country

CHINA
🏢

Address

No. 88 Yunxiang Road, Tonghe Street, Baiyun District, Guangzhou, Guangdong, China

Moderate Risk

FDA Import Risk Assessment

42.8
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
5
Unique Violations
10/3/2023
Latest Refusal
11/22/2011
Earliest Refusal

Score Breakdown

Violation Severity
64.4×40%
Refusal Volume
28.8×30%
Recency
40.0×20%
Frequency
4.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4761×

NO REGISTR

The article appears to be an electronic product that does not comply with an applicable standard as prescribed by Section 534 because no reporting has been provided as required by Section 537(b).

Refusal History

DateProductViolationsDivision
10/3/2023
61XDE08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/30/2014
60LBY99ANALGESIC, N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/27/2014
60LBY99ANALGESIC, N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/16/2012
66VAJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
11/22/2011
95RDZLOW-POWER LASER LIGHT SHOW PROJECTOR, DISPLAY PRODUCTS
476NO REGISTR
San Francisco District Office (SAN-DO)

Frequently Asked Questions

What is Guangzhou Baiyunshan Pharmaceutical Factory's FDA import refusal history?

Guangzhou Baiyunshan Pharmaceutical Factory (FEI: 3006532121) has 5 FDA import refusal record(s) in our database, spanning from 11/22/2011 to 10/3/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Guangzhou Baiyunshan Pharmaceutical Factory's FEI number is 3006532121.

What types of violations has Guangzhou Baiyunshan Pharmaceutical Factory received?

Guangzhou Baiyunshan Pharmaceutical Factory has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Guangzhou Baiyunshan Pharmaceutical Factory come from?

All FDA import refusal data for Guangzhou Baiyunshan Pharmaceutical Factory is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.